Table 1

Patient selection for BPA

IndicationFeasibilityJustification
Inoperable CTEPHVenous access to PAsVolume of treatable disease likely to lead to significant haemodynamic benefit
Symptomatic on medical therapy or intolerant of PH-targeted therapyAble to breath-holdTreatable disease supplies viable lung—guided by CT and PFTs
Comorbidity not the dominant cause of symptomsBalloon-treatable lesions identified by pulmonary angiogram/CT
  • BPA, balloon pulmonary angioplasty; CTEPH, chronic thromboembolic pulmonary hypertension; PA, pulmonary artery; PFT, pulmonary function test; PH, pulmonary hypertension.